Stephen A. Beers

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Tailored FcγR blockade enhances immune checkpoint therapy and overcomes resistance.

Tailored FcγR blockade enhances immune checkpoint therapy and overcomes resistance.

Journal: Journal of experimental & clinical cancer research : CR
Published: March 30, 2026

Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Employ Distinct Modes of Action to Induce Antitumor Immunity.

Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Employ Distinct Modes of Action to Induce Antitumor Immunity.

Journal: Cancer research
Published: January 16, 2026

CenSegNet: a generalist high-throughput deep learning framework for centrosome phenotyping at spatial and single-cell resolution in heterogeneous tissues.

CenSegNet: a generalist high-throughput deep learning framework for centrosome phenotyping at spatial and single-cell resolution in heterogeneous tissues.

Journal: Nature communications
Published: October 29, 2025

Author Correction: Development and characterisation of a novel 3D in vitro model of obesity-associated breast cancer as a tool for drug testing.

Author Correction: Development and characterisation of a novel 3D in vitro model of obesity-associated breast cancer as a tool for drug testing.

Journal: NPJ breast cancer
Published: September 13, 2025

Development and characterisation of a novel 3D in vitro model of obesity-associated breast cancer as a tool for drug testing.

Development and characterisation of a novel 3D in vitro model of obesity-associated breast cancer as a tool for drug testing.

Journal: NPJ breast cancer
Published: January 14, 2025

Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Journal: Nature communications
Published: December 10, 2024

The ETS-family transcription factor PU.1 is a critical regulator of the inhibitory Fcγ receptor IIB expression in humans.

The ETS-family transcription factor PU.1 is a critical regulator of the inhibitory Fcγ receptor IIB expression in humans.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 04, 2024

A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy.

A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy.

Journal: Cancer immunology research
Published: November 04, 2024

Comparison of human macrophages derived from peripheral blood and bone marrow.

Comparison of human macrophages derived from peripheral blood and bone marrow.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 12, 2024

Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges.

Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 08, 2023

Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.

Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.

Journal: Biochimica et biophysica acta. General subjects
Published: July 05, 2023

The role of three-dimensional in vitro models in modelling the inflammatory microenvironment associated with obesity in breast cancer.

The role of three-dimensional in vitro models in modelling the inflammatory microenvironment associated with obesity in breast cancer.

Journal: Breast cancer research : BCR
Published: July 04, 2023
Showing 1-12 of 62

Last Updated: 09/26/2026